Flagopen Injection contains Meropenem 500mg, a broad-spectrum carbapenem antibiotic used to treat a variety of serious bacterial infections. It is effective against a wide range of gram-positive and gram-negative bacteria, including strains resistant to other antibiotics. Flagopen works by inhibiting bacterial cell wall synthesis, leading to cell death and resolution of infection. It is commonly prescribed for complicated intra-abdominal infections, bacterial meningitis, skin and soft tissue infections, and urinary tract infections caused by susceptible organisms. Administered intravenously, Flagopen Injection ensures rapid and effective delivery of the active ingredient, making it suitable for severe infections requiring hospital care. The dosage and duration of treatment depend on the type and severity of the infection, as well as patient-specific factors such as age and kidney function. Common side effects may include nausea, diarrhea, rash, and injection site reactions, though serious adverse effects are rare. Caution is advised in patients with a history of hypersensitivity to beta-lactam antibiotics. Flagopen Injection should be used under medical supervision to ensure appropriate use and to help prevent the development of antibiotic resistance. It is essential to complete the full prescribed course even if symptoms improve earlier.